Guillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist's journey

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 88, Issue 7, 2012, Pages 299-326

  Yuki, Nobuhiro ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Autoimmune disease; Campylobacter jejuni; Fisher syndrome; Ganglioside; Guillain Barr syndrome; Molecular mimicry

Indexed keywords

ANTIBODY; GANGLIOSIDE;

ANIMAL; CLASSIFICATION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOLOGY; MEDICAL RESEARCH; PATHOLOGY; PATHOPHYSIOLOGY; PERSONNEL; REVIEW;

ANIMALS; ANTIBODIES; BIOMEDICAL RESEARCH; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; MILLER FISHER SYNDROME; RESEARCH PERSONNEL;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER JEJUNI;

EID: 84867034919     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.88.299     Document Type: Review

References (186)

1. Hughes, R.A.C., Swan, A.V., Raphaël, J.C., Annane, D., van Koningsveld, R. and van Doorn, P.A. (2007) Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 130, 2245-2257.
2. Feasby, T.E., Gilbert, J.J., Brown, W.F., Bolton, C.F., Hahn, A.F., Koopman, W.F. and Zochodne, D.W. (1986) An acute axonal form of Guillain-Barré polyneuropathy. Brain 109, 1115-1126.
3. Freddo, L., Yu, R.K., Latov, N., Donofrio, P.D., Hays, A.P., Greenberg, H.S., Albers, J.W., Allessi, A.G. and Keren, D. (1986) Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36, 454-458.
4. Yuki, N., Yoshino, H., Sato, S. and Miyatake, T. (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylo-bacter enteritis. Neurology 40, 1900-1902.
5. Kaldor, J. and Speed, B.R. (1984) Guillain-Barré syndrome associated with Campylobacter jejuni: a serological study. Br. Med. J. (Clin. Res. Ed.) 288, 1867-1870.
6. Rhodes, K.M. and Tattersfield, A.E. (1982) Guillain-Barré syndrome associated with Campylobacter infection. Br. Med. J. (Clin. Res. Ed.) 285, 173-174.
7. Yuki, N., Yoshino, H., Sato, S. and Miyatake, T. (1991) Campylobacter neuropathy: reply. Neurology 41, 1328.
8. Ogawara, K., Kuwabara, S., Mori, M., Hattori, T., Koga, M. and Yuki, N. (2000) Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 48, 624-631.
9. Ho, T.W., Willison, H.J., Nachamkin, I., Li, C.Y., Veitch, J., Ung, H., Wang, G.R., Liu, R.C., Cornblath, D.R., Asbury, A.K., Griffin, J.W. and Mckhann, G.M. (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45, 168-173.
10. Willison, H.J. (2011) Biomarkers in experimental models of antibody-mediated neuropathies. J. Peripher. Nerv. Syst. 16 (Suppl. 1), 60-62.
11. Koblar, S.A., Gregson, N.A., Hughes, R.A.C., Doherty, P. and Walsh, F.S. (1991) Campylobacter neuropathy. Neurology 41, 1327-1328.
12. van der Meché, F.G.A., Oomes, P.G., Kleyweg, R.P., Banffer, J.R. and Meulstee, J. (1991) Axonal Guillain-Barré. Neurology 41, 1530-1531.
13. Rees, J.H., Soudain, S.E., Gregson, N.A. and Hughes, R.A.C. (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333, 1374-1379.
14. Bradley, W.G. (1990) Critical review of gangliosides and thyrotropin-releasing hormone in peripheral neuromuscular diseases. Muscle Nerve 13, 833-842.
15. Yuki, N., Sato, S., Miyatake, T., Sugiyama, K., Katagiri, T. and Sasaki, H. (1991) Motoneurondisease-like disorder after ganglioside therapy. Lancet 337, 1109-1110.
16. Yuki, N., Sato, S., Miyatake, T., Sugiyama, K., Katagiri, T. and Sasaki, H. (1991) Motoneurondisease-like disorder after ganglioside therapy: reply. Lancet 338, 314-315.
17. Yuki, N., Miyatake, T., Ichihashi, Y., Sato, S. and Katagiri, T. (1992) IgM anti-(GalNAc O1-4 Gal[3-2, NeuAc] O1-) antibody-mediated cytotoxicity in a patient with amyotrophic lateral sclerosis-like disorder. Muscle Nerve 15, 1371-1373.
18. Matsumoto, A., Yoshino, H., Yuki, N., Hara, Y., Cashman, N.R., Handa, S. and Miyatake, T. (1995) Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons. J. Neurol. Sci. 131, 111-118.
19. Mitsumoto, H., Sliman, R.J., Schafer, I.A., Sternick, C.S., Kaufman, B., Wilbourn, A. and Horwitz,S.J. (1985) Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann. Neurol. 17, 378-385.
20. Nakao, T., Kon, K., Ando, S., Miyatake, T., Yuki, N., Li, Y.T., Furuya, S. and Hirabayashi, Y. (1993) Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder. J. Biol. Chem. 268, 21028-21034.
21. Nakashima, S., Ando, H., Imamura, A., Yuki, N., Ishida, H. and Kiso, M. (2011) A first total synthesis of a hybrid-type ganglioside associated with amyotrophic lateral sclerosis-like disorder. Chemistry 17, 588-597.
22. Nakashima, S., Ando, H., Saito, R., Tamai, H., Ishida, H. and Kiso, M. (2012) Efficiently synthesizing lacto-ganglio-series gangliosides by using a glucosyl ceramide cassette approach: the total synthesis of ganglioside X2. Chem. Asian J. 7, 1041-1051.
23. Schönhöfer, P.S. (1991) Guillain-Barré syndrome and parenteral gangliosides. Lancet 338, 757.
24. Figueras, A., Morales-Olivas, F.J., Capella, D., Palop, V. and Laporte, J.R. (1992) Bovine gangliosides and acute motor polyneuropathy. BMJ 305, 1330-1331.
25. Landi, G., D'Alessandro, R., Dossi, B.C., Ricci, S., Simone, I.L. and Ciccone, A. (1993) Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ 307, 1463-1464.
26. Yuki, N., Yamada, M., Koga, M., Odaka, M., Susuki, K., Tagawa, Y., Ueda, S., Kasama, T., Ohnishi, A., Hayashi, S., Takahashi, H., Kamijo, M. and Hirata, K. (2001) Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49, 712-720.
27. Yuki, N., Handa, S., Taki, T., Kasama, T., Takahashi, M., Saito, K., and Miyatake, T. (1992) Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13, 451-453.
28. Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S. and Miyatake, T. (1993) A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178, 1771-1775.
29. Koga, M., Gilbert, M., Takahashi, M., Li, J., Koike, S., Hirata, K. and Yuki, N. (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain-Barré syndrome after Campylobacter jejuni enteritis. J. Infect. Dis. 193, 547-555.
30. Aspinall, G.O., McDonald, A.G., Raju, T.S., Pang, H., Mills, S.D., Kurjanczyk, L.A. and Penner, J.L. (1992) Serological diversity and chemical structures of Campylobacter jejuni low-molecular-weight lipopolysaccharides. J. Bacteriol. 174, 1324-1332.
31. Aspinall, G.O., McDonald, A.G., Pang, H., Kurjanczyk, L.A. and Penner, J.L. (1994) Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33, 241-249.
32. Yuki, N. and Tsujino, Y. (1995) Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Pediatr. 126, 162.
33. Chiba, A., Kusunoki, S., Shimizu, T. and Kanazawa, I. (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31, 677-679.
34. Yuki, N., Sato, S., Tsuji, S., Hozumi, I. and Miyatake, T. (1993) An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J. Neurol. Sci. 118, 83-87.
35. Triggs, W.J. and Cros, D. (1993) Axonal Guillain-Barré syndrome. Neurology 43, 1443-1444.
36. Triggs, W.J., Cros, D., Gominak, S.C., Zuniga, G., Beric, A., Shahani, B.T., Ropper, A.H. and Roongta, S.M. (1992) Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration. Brain 115 (Pt. 5), 1291-1302.
37. Yuki, N., Sato, S., Itoh, T. and Miyatake, T. (1991) HLA-B35 and acute axonal polyneuropathy following Campylobacter infection. Neurology 41, 1561-1563.
38. Yuki, N., Yoshino, H., Sato, S., Shinozawa, K. and Miyatake, T. (1992) Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15, 899-903.
39. Yuki, N. and Miyatake, T. (1993) Axonal Guillain-Barré syndrome: reply. Neurology 43, 1443-1444.
40. Dyck, P.J. (1993) Is there an axonal variety of GBS? Neurology 43, 1277-1280.
41. Cros, D. and Triggs, W.J. (1994) There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome. Muscle Nerve 17, 675-677.
42. Feasby, T.E. (1994) Axonal Guillain-Barré syndrome. Muscle Nerve 17, 678-679.
43. Yuki, N. (1994) Pathogenesis of axonal Guillain-Barré syndrome: hypothesis. Muscle Nerve 17, 680-682.
44. McKhann, G.M., Cornblath, D.R., Ho, T., Griffin, J.W., Li, C.Y., Bai, A.Y., Wu, H.S., Yei, Q.F., Zhang, W.C., Zhaori, Z., Jiang, Z. and Asbury, A.K. (1991) Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 338, 593-597.
45. Yuki, N., Yoshino, H. and Miyatake, T. (1993) Acute paralytic disease in Japan. Lancet 341, 831.
46. Griffin, J.W., Li, C.Y., Ho, T.W., Tian, M., Gao, C.Y., Xue, P., Mishu, B., Cornblath, D.R., Macko, C., McKhann, G.M. and Asbury, A.K. (1996) Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann. Neurol. 39, 17-28.
47. Griffin, J.W., Li, C.Y., Ho, T.W., Xue, P., Macko, C., Gao, C.Y., Yang, C., Tian, M., Mishu, B. and Cornblath, D.R. (1995) Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 118, 577-595.
48. Griffin, J.W., Li, C.Y., Macko, C., Ho, T.W., Hsieh, S.T., Xue, P., Wang, F.A., Cornblath, D.R., McKhann, G.M. and Asbury, A.K. (1996) Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J. Neurocytol. 25, 33-51.
49. Hafer-Macko, C., Hsieh, S.-T., Li, C.Y., Ho, T.W., Sheikh, K., Cornblath, D.R., McKhann, G.M., Asbury, A.K. and Griffin, J.W. (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40, 635-644.
50. Hafer-Macko, C.E., Sheikh, K.A., Li, C.Y., Ho, T.W., Cornblath, D.R., McKhann, G.M., Asbury, A.K. and Griffin, J.W. (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39, 625-635.
51. Ho, T.W., Mishu, B., Li, C.Y., Gao, C.Y., Cornblath, D.R., Griffin, J.W., Asbury, A.K., Blaser, M.J. and McKhann, G.M. (1995) Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118, 597-605.
52. Asbury, A.K. (1981) Diagnostic considerations in Guillain-Barré syndrome. Ann. Neurol. 9 (Suppl.), 1-5.
53. Asbury, A.K., Arnason, B.G., Karp, H.R. and McFarlin, D.E. (1978) Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3, 565-566.
54. Asbury, A.K. and Cornblath, D.R. (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27 (Suppl.), S21-S24.
55. Yuki, N. and Hirata, K. (1998) Preserved tendon reflexes in Campylobacter neuropathy. Ann. Neurol. 43, 546-547.
56. Asbury, A.K. and Cornblath, D.R. (1998) Preserved tendon reflexes in Campylobacter neuropathy: reply. Ann. Neurol. 43, 547.
57. Kuwabara, S., Nakata, M., Sung, J.Y., Mori, M., Kato, N., Hattori, T., Koga, M. and Yuki, N. (2002) Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Neurol. Sci. 199, 89-92.
58. Yuki, N., Kokubun, N., Kuwabara, S., Sekiguchi, Y., Ito, M., Odaka, M., Hirata, K., Notturno, F. and Uncini, A. (2012) Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J. Neurol. 259, 1181-1190.
59. van der Meché, F.G.A., Meulstee, J., Vermeulen, M. and Kievit, A. (1988) Patterns of conduction failure in the Guillain-Barré syndrome. Brain111, 405-416.
60. Podnar, S. and Vodusek, D.B. (2000) Hyperreflexia in a patient with motor axonal Guillain-Barré syndrome. Eur. J. Neurol. 7, 727-730.
61. Kuwabara, S., Ogawara, K., Koga, M., Mori, M., Hattori, T. and Yuki, N. (1999) Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J. Neurol. Neurosurg. Psychiatry 67, 180-184.
62. McKhann, G.M., Cornblath, D.R., Griffin, J.W., Ho, T.W., Li, C.Y., Jiang, Z., Wu, H.S., Zhaori, G., Liu, Y., Jou, L.P., Liu, T.C., Gao, C.Y., Mao, J.Y., Blaser, M.J., Mishu, B. and Asbury, A.K. (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33, 333-342.
63. Nagai, Y., Momoi, T., Saito, M., Mitsuzawa, E. and Ohtani, S. (1976) Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci. Lett. 2, 107-111.
64. Yuki, N., Mori, I. and Susuki, K. (2002) Rabbit model of Guillain-Barré syndrome: reply. Ann. Neurol. 52, 128-129.
65. Thomas, F.P., Trojaborg, W., Nagy, C., Santoro, M., Sadiq, S.A., Latov, N. and Hays, A.P. (1991) Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 82, 378-383.
66. Kusunoki, S., Shimizu, J., Chiba, A., Ugawa, Y., Hitoshi, S. and Kanazawa, I. (1996) Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann. Neurol. 39, 424-431.
67. Comín, R., Yuki, N., Lopez, P.H. and Nores, G.A. (2006) High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy. J. Neurosci. Res. 84, 1085-1090.
68. Susuki, K., Nishimoto, Y., Yamada, M., Baba, M., Ueda, S., Hirata, K. and Yuki, N. (2003) Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann. Neurol. 54, 383-388.
69. Sheikh, K.A. and Griffin, J.W. (2001) Variants of the Guillain Barré syndrome: progress toward fulfilling "Koch's postulates". Ann. Neurol. 49, 694-696.
70. Nachamkin, I. (2002) Rabbit model of Guillain-Barré syndrome. Ann. Neurol. 52, 127-128.
71. Susuki, K., Nishimoto, Y., Koga, M., Nagashima, T., Mori, I., Hirata, K. and Yuki, N. (2004) Various immunization protocols for an acute motor axonal neuropathy rabbit model compared. Neurosci. Lett. 368, 63-67.
72. Toyka, K.V., Zielasek, J. and Stoll, G. (2002) Myelin-derived glycolipids and animal models of Guillain-Barré syndrome. Ann. Neurol. 51, 532; author reply 532-533.
73. Kusunoki, S., Hitoshi, S., Kaida, K., Murayama, S. and Kanazawa, I. (1999) Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum. Neurosci. Lett. 273, 33-36.
74. Saida, K., Saida, T., Brown, M.J., Silberberg, D.H. and Asbury, A.K. (1978) Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab. Invest. 39, 449-462.
75. Yuki, N., Susuki, K., Koga, M., Nishimoto, Y. and Kamijo, M. (2002) Myelin-derived glycolipids and animal models of Guillain-Barré syndrome: reply. Ann. Neurol. 51, 532-533.
76. Goodfellow, J.A., Bowes, T., Sheikh, K., Odaka, M., Halstead, S.K., Humphreys, P.D., Wagner, E.R., Yuki, N., Furukawa, K., Furukawa, K., Plomp, J.J. and Willison, H.J. (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J. Neurosci. 25, 1620-1628.
77. Greenshields, K.N., Halstead, S.K., Zitman, F.M., Rinaldi, S., Brennan, K.M., O'Leary, C., Chamberlain, L.H., Easton, A., Roxburgh, J., Pediani, J., Furukawa, K., Furukawa, K., Goodyear, C.S., Plomp, J.J. and Willison, H.J. (2009) The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J. Clin. Invest. 119, 595-610.
78. Koga, M., Gilbert, M., Li, J., Koike, S., Takahashi, M., Furukawa, K., Hirata, K. and Yuki, N. (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64, 1605-1611.
79. Yuki, N., Susuki, K., Koga, M., Nishimoto, Y., Odaka, M., Hirata, K., Taguchi, K., Miyatake, T., Furukawa, K., Kobata, T. and Yamada, M. (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. U.S.A. 101, 11404-11409.
80. Caporale, C.M., Capasso, M., Luciani, M., Prencipe, V., Creati, B., Gandolfi, P., de Angelis, M.V., Di Muzio, A., Caporale, V. and Uncini, A. (2006) Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome. J. Neuroimmunol. 174, 12-20.
81. Marrack, P., Kappler, J. and Kotzin, B.L. (2001) Autoimmune disease: why and where it occurs. Nat. Med. 7, 899-905.
82. Ang, C.W., Jacobs, B.C. and Laman, J.D. (2004) The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol. 25, 61-66.
83. Yuki, N. (2005) Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr. Opin. Immunol. 17, 577-582.
84. Hirota, N., Kaji, R., Bostock, H., Shindo, K., Kawasaki, T., Mizutani, K., Oka, N., Kohara, N., Saida, T. and Kimura, J. (1997) The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 120, 2159-2169.
85. Takigawa, T., Yasuda, H., Kikkawa, R., Shigeta,Y., Saida, T. and Kitasato, H. (1995) Antibodies against GM1 ganglioside affect KD and NaD currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37, 436-442.
86. Ishibashi, T., Dupree, J.L., Ikenaka, K., Hirahara, Y., Honke, K., Peles, E., Popko, B., Suzuki, K., Nishino, H. and Baba, H. (2002) A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J. Neurosci. 22, 6507-6514.
87. Susuki, K., Baba, H., Tohyama, K., Kanai, K., Kuwabara, S., Hirata, K., Furukawa, K., Furukawa, K., Rasband, M.N. and Yuki, N. (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55, 746-757.
88. Hadden, R.D.M., Cornblath, D.R., Hughes, R.A.C., Zielasek, J., Hartung, H.P., Toyka, K.V. and Swan, A.V. (1998) Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann. Neurol. 44, 780-788.
89. Enders, U., Karch, H., Toyka, K.V., Michels, M., Zielasek, J., Pette, M., Heesemann, J. and Hartung, H.P. (1993) The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34, 136-144.
90. Vriesendorp, F.J., Mishu, B., Blaser, M.J. and Koski, C.L. (1993) Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann. Neurol. 34, 130-135.
91. Kuwabara, S., Yuki, N., Koga, M., Hattori, T., Matsuura, D., Miyake, M. and Noda, M. (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann. Neurol. 44, 202-208.
92. Kuwabara, S., Ogawara, K., Misawa, S., Koga, M., Mori, M., Hiraga, A., Kanesaka, T., Hattori, T. and Yuki, N. (2004) Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barré syndrome? Neurology 63, 529-533.
93. Hiraga, A., Kuwabara, S., Ogawara, K., Misawa, S., Kanesaka, T., Koga, M., Yuki, N., Hattori, T. and Mori, M. (2005) Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Neurology 64, 856-860.
94. Kokubun, N., Nishibayashi, M., Uncini, A., Odaka, M., Hirata, K. and Yuki, N. (2010) Conduction block in acute motor axonal neuropathy. Brain 133, 2897-2908.
95. Uncini, A., Manzoli, C., Notturno, F. and Capasso, M. (2010) Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J. Neurol. Neurosurg. Psychiatry 81, 1157-1163.
96. Susuki, K., Rasband, M.N., Tohyama, K., Koibuchi, K., Okamoto, S., Funakoshi, K., Hirata, K., Baba, H. and Yuki, N. (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 27, 3956-3967.
97. Waxman, S.G. (1995) Sodium channel blockade by antibodies: a new mechanism of neurological disease? Ann. Neurol. 37, 421-423.
98. Guillain-Barré. Syndrome Steroid Trial Group (1993) Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 341, 586-590.
99. Hughes, R.A.C., Newsom-Davis, J.M., Perkin, G.D. and Pierce, J.M. (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2, 750-753.
100. Yuki, N., Kuwabara, S., Koga, M. and Hirata, K. (1999) Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J. Neurol. Sci. 168, 121-126.
101. Capasso, M., Notturno, F., Mazoli, C. and Uncini, A. (2011) Involvement of sensory fibers in axonal subtypes of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 82, 664-670.
102. Capasso, M., Caporale, C.M., Pomilio, F., Gandolfi, P., Lugaresi, A. and Uncini, A. (2003) Acute motor conduction block neuropathy: another Guillain-Barré syndrome variant. Neurology 61, 617-622.
103. Yuki, N. and Saperstein, D.S. (2003) Axonal Guillain-Barré syndrome subtypes: do we need more splitting? Neurology 61, 598-599.
104. Uncini, A. and Yuki, N. (2009) Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes. Expert Rev. Neurother. 9, 869-884.
105. Yuki, N. and Shahrizaila, N. (2011) Keeping it simple: is there a need for the various subtyping of axonal forms of Guillain-Barré syndrome? J. Neurol. Neurosurg. Psychiatry 82, 592.
106. Pan, C.L., Yuki, N., Koga, M., Chiang, M.C. and Hsieh, S.T. (2001) Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology 57, 1316-1318.
107. Susuki, K., Yuki, N., Schafer, D.P., Hirata, K., Zhang, G., Funakoshi, K. and Rasband, M.N. (2011) Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp. Neurol. 233, 534-542.
108. The Guillain-Barré syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35, 1096-1104.
109. Lu, M.O. and Zhu, J. (2011) The role of cytokines in Guillain-Barré syndrome. J. Neurol. 258, 533-548.
110. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 349, 225-230.
111. Yuki, N., Tagawa, Y. and Hirata, K. (1998) Minimal number of plasma exchanges needed toreduce immunoglobulin in Guillain-Barré syndrome. Neurology 51, 875-877.
112. Yuki, N. and Miyagi, F. (1996) Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies. J. Neurol. Sci. 139, 160-162.
113. Malik, U., Oleksowicz, L., Latov, N. and Cardo, L.J. (1996) Intravenous .-globulin inhibits binding of anti-GM1 to its target antigen. Ann. Neurol. 39, 136-139.
114. Nishimoto, Y., Koga, M., Kamijo, M., Hirata, K. and Yuki, N. (2004) Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration. Neurology 62, 1939-1944.
115. Pestronk, A., Cornblath, D.R., Ilyas, A.A., Baba, H., Quarles, R.H., Griffin, J.W., Alderson, K. and Adams, R.N. (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24, 73-78.
116. Yuki, N., Watanabe, H., Nakajima, T. and Späth, P.J. (2010) IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry 82, 87-91.
117. Willison, H.J., Halstead, S.K., Beveridge, E., Zitman, F.M., Greenshields, K.N., Morgan, B.P. and Plomp, J.J. (2008) The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barré syndrome. J. Neuroimmunol. 201-202, 172-182.
118. Halstead, S.K., Humphreys, P.D., Goodfellow, J.A., Wagner, E.R., Smith, R.A. and Willison, H.J. (2005) Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann. Neurol. 58, 203-210.
119. Halstead, S.K., Humphreys, P.D., Zitman, F.M., Hamer, J., Plomp, J.J. and Willison, H.J. (2008) C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. J. Peripher. Nerv. Syst. 13, 228-235.
120. Phongsisay, V., Susuki, K., Matsuno, K., Yamahashi, T., Okamoto, S., Funakoshi, K., Hirata, K., Shinoda, M. and Yuki, N. (2008) Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome. J. Neuroimmunol. 205, 101-104.
121. Haber, P., Sejvar, J., Mikaeloff, Y. and DeStefano, F. (2009) Vaccines and Guillain-Barré syndrome. Drug Saf. 32, 309-323.
122. Yuki, N. and Kuwabara, S. (2007) Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J. Peripher. Nerv. Syst. 12, 238-249.
123. Dieleman, J., Romio, S., Johansen, K., Weibel, D., Bonhoeffer, J. and Sturkenboom, M. (2011) Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 343, d3908.
124. Yuki, N., Takahashi, Y., Ihara, T., Ito, S., Nakajima, T., Funakoshi, K., Furukawa, K., Kobayashi, K. and Odaka, M. (2012) Lack of antibody response to Guillain-Barré syndromerelated gangliosides in mice and men after novel flu vaccination. J. Neurol. Neurosurg. Psychiatry 83, 116-117.
125. Hemachudha, T., Griffin, D.E., Giffels, J.J., Johnson, R.T., Moser, A.B. and Phanuphak, P. (1987) Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N. Engl. J. Med. 316, 369-374.
126. Laouini, D., Kennou, M.F., Khoufi, S. and Dellagi, K. (1998) Antibodies to human myelin proteins and gangliosides in patients with acute neuroparalytic accidents induced by brain-derived rabies vaccine. J. Neuroimmunol. 91, 63-72.
127. Fisher, M. (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255, 57-65.
128. Jibiki, T., Shimizu, N., Terashima, I. and Yuki, N. (1994) Guillain-Barré syndrome associated with anti-GQ1b antibody: nosological relationship between Fisher's syndrome and Guillain-Barré syndrome. Rinsho Shinkeigaku 34, 381-384.
129. Koga, M., Yuki, N. and Hirata, K. (2001) Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups. Acta Neurol. Scand. 103, 278-287.
130. Yuki, N., Sato, S., Tsuji, S., Ohsawa, T. and Miyatake, T. (1993) Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43, 414-417.
131. Roberts, T., Shah, A., Graham, J.G. and McQueen, I.N. (1987) The Miller Fischer syndrome following campylobacter enteritis: a report of two cases. J. Neurol. Neurosurg. Psychiatry 50, 1557-1558.
132. Yuki, N., Taki, T., Takahashi, M., Saito, K., Yoshino, H., Tai, T., Handa, S. and Miyatake, T. (1994) Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36, 791-793.
133. Nam Shin, J.E., Ackloo, S., Mainkar, A.S., Monteiro, M.A., Pang, H., Penner, J.L. and Aspinall, G.O. (1997) Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr. Res. 305, 223-232.
134. Kimoto, K., Koga, M., Odaka, M., Hirata, K., Takahashi, M., Li, J., Gilbert, M. and Yuki, N. (2006) Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 67, 1837-1843.
135. Funakoshi, K., Koga, M., Takahashi, M., Hirata, K. and Yuki, N. (2006) Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.J. Neurol. Sci. 246, 163-168.
136. Koga, M., Yuki, N., Takahashi, M., Saito, K. and Hirata, K. (1999) Are Campylobacter curvus and Campylobacter upsaliensis antecedent infectious agents in Guillain-Barré and Fisher's syndromes? J. Neurol. Sci. 163, 53-57.
137. Koga, M., Koike, S., Hirata, K. and Yuki, N. (2005) Ambiguous value of Haemophilus influenzae isolation in Guillain-Barré and Fisher syndromes. J. Neurol. Neurosurg. Psychiatry 76, 1736-1738.
138. Houliston, R.S., Koga, M., Li, J., Jarrell, H.C., Richards, J.C., Vitiazeva, V., Schweda, E.K., Yuki, N. and Gilbert, M. (2007) A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry 46, 8164-8171.
139. Koga, M., Yuki, N., Takahashi, M., Saito, K. and Hirata, K. (1998) Close association of IgA antiganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes. J. Neuroimmunol. 81, 138-143.
140. Koga, M., Yuki, N., Tai, T. and Hirata, K. (2001) Miller Fisher syndrome and Haemophilus influenzae infection. Neurology 57, 686-691.
141. Mori, M., Kuwabara, S., Miyake, M., Noda, M., Kuroki, H., Kanno, H., Ogawara, K. and Hattori, T. (2000) Haemophilus influenzae infection and Guillain-Barré syndrome. Brain 123, 2171-2178.
142. Shahrizaila, N. and Yuki, N. (2011) Helicobacter pylori infection may trigger Guillain-Barré syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis: reply. J. Neurol. Sci. 305, 169.
143. Kuroki, S., Haruta, T., Yoshioka, M., Kobayashi, Y., Nukina, M. and Nakanishi, H. (1991) Guillain-Barré syndrome associated with Campylobacter infection. Pediatr. Infect. Dis. J. 10, 149-151.
144. Yuki, N., Takahashi, M., Tagawa, Y., Kashiwase, K., Tadokoro, K. and Saito, K. (1997) Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Ann. Neurol. 42, 28-33.
145. Takahashi, M., Koga, M., Yokoyama, K. and Yuki, N. (2005) Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan. J. Clin. Microbiol. 43, 335-339.
146. Gilbert, M., Karwaski, M.F., Bernatchez, S., Young, N.M., Taboada, E., Michniewicz, J., Cunningham, A.M. and Wakarchuk, W.W. (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni: biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 277, 327-337.
147. Koga, M., Takahashi, M., Masuda, M., Hirata, K. and Yuki, N. (2005) Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 65, 1376-1381.
148. Gilbert, M., Brisson, J.R., Karwaski, M.F., Michniewicz, J., Cunningham, A.M., Wu, Y., Young, N.M. and Wakarchuk, W.W. (2000) Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384: identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-MHz 1H and 13CNMR analysis. J. Biol. Chem. 275, 3896-3906.
149. Godschalk, P.C.R., Heikema, A.P., Gilbert, M., Komagamine, T., Ang, C.W., Glerum, J., Brochu, D., Li, J., Yuki, N., Jacobs, B.C., van Belkum, A. and Endtz, H.P. (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. J. Clin. Invest. 114, 1659-1665.
150. Gilbert, M., Godschalk, P.C.R., Parker, C.T., Endtz, H.P. and Wakarchuk, W.W. (2005) Genetic bases for the variation in the lipooligosaccharide outer core of Campylobacter jejuni and possible association of glycosyltransferase genes with postinfectious neuropathies. In Campylobacter: Molecular And Cellular Biology (eds. Ketley, J. and Konkel, M.). Horizon Scientific Press, Norwich, UK, pp. 219-248.
151. Chiba, A., Kusunoki, S., Obata, H., Machinami, R. and Kanazawa, I. (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43, 1911-1917.
152. Liu, J.X., Willison, H.J. and Pedrosa-Domellof, F. (2009) Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest. Ophthalmol. Vis. Sci. 50, 3226-3232.
153. Kusunoki, S., Chiba, A. and Kanazawa, I. (1999) Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22, 1071-1074.
154. Mori, M., Kuwabara, S., Fukutake, T., Yuki, N. and Hattori, T. (2001) Clinical features and prognosis of Miller Fisher syndrome. Neurology 56, 1104-1106.
155. Bickerstaff, E.R. and Cloake, P.C. (1951) Mesencephalitis and rhombencephalitis. Br. Med. J. 2 (4723), 77-81.
156. Bickerstaff, E.R. (1957) Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br. Med. J. 15, 1384-1387.
157. Al-Din, A.N., Anderson, M., Bickerstaff, E.R. and Harvey, I. (1982) Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain 105, 481-495.
158. Ropper, A.H. (1983) The CNS in Guillain-Barré syndrome. Arch. Neurol. 40, 397-398.
159. Ito, M., Kuwabara, S., Odaka, M., Misawa, S., Koga, M., Hirata, K. and Yuki, N. (2008) Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J. Neurol. 255, 674-682.
160. Odaka, M., Yuki, N., Yamada, M., Koga, M., Takemi, T., Hirata, K. and Kuwabara, S. (2003)Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 126, 2279-2290.
161. Yuki, N. (1996) Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol. 39, 668-672.
162. Yuki, N., Susuki, K. and Hirata, K. (2000) Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 54, 1851-1853.
163. Yuki, N., Odaka, M. and Hirata, K. (2001) Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 108, 196-200.
164. Yuki, N., Koga, M. and Hirata, K. (1998) Isolated internal ophthalmoplegia associated with immunoglobulin G anti-GQ1b antibody. Neurology 51, 1515-1516.
165. O'Leary, C.P., Veitch, J., Durward, W.F., Thomas, A.M., Rees, J.H. and Willison, H.J. (1996) Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry 61, 649-651.
166. Nagashima, T., Koga, M., Odaka, M., Hirata, K. and Yuki, N. (2007) Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch. Neurol. 64, 1519-1523.
167. Ropper, A.H. (1986) Unusual clinical variants and signs in Guillain-Barré syndrome. Arch. Neurol. 43, 1150-1152.
168. Arai, M., Susuki, K. and Koga, M. (2003) Axonal pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without anti-GT1a IgG antibody. Muscle Nerve 28, 246-250.
169. Capasso, M., Notturno, F., Manzoli, C., Yuki, N. and Uncini, A. (2010) Reversible conduction failure in pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Muscle Nerve 42, 608-612.
170. Richter, R.B. (1962) The ataxic form of polyradiculoneuritis (Landry-Guillain-Barré syndrome): clinical and pathologic observations. J. Neuropathol. Exp. Neurol. 21, 171-184.
171. Ropper, A.H. (1994) Further regional variants of acute immune polyneuropathy: bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngealcervical-brachial weakness. Arch. Neurol. 51, 671-675.
172. Tatsumoto, M., Odaka, M., Hirata, K. and Yuki, N. (2006) Isolated abducens nerve palsy as a regional variant of Guillain-Barré syndrome. J. Neurol. Sci. 243, 35-38.
173. Nagashima, T., Odaka, M., Koga, M., Yuki, N. and Hirata, K. (2002) A case of pharyngeal-cervicalbrachial weakness suggestive of the nosological continuity between acute oropharyngeal palsy. Rinsho Shinkeigaku 42, 523-526.
174. Willison, H.J. and Veitch, J. (1994) Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J. Neuroimmunol. 50, 159-165.
175. Yuki, N., Ichihashi, Y. and Taki, T. (1995) Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome. J. Neuroimmunol. 60, 161-164.
176. Jacobs, B.C., Koga, M., van Rijs, W., Geleijns, K., van Doorn, P.A., Willison, H.J. and Yuki, N. (2008) Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome. J. Neuroimmunol. 194, 181-190.
177. Koga, M., Yuki, N., Hirata, K., Morimatsu, M., Mori, M. and Kuwabara, S. (2003) Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome. Neurology 60, 1514-1518.
178. Koga, M., Yuki, N., Tsukada, Y., Hirata, K. and Matsumoto, Y. (2003) CDR3 spectratyping analysis of the T cell receptor repertoire in Guillain-Barré and Fisher syndromes. J. Neuroimmunol. 141, 112-117.
179. Matsumoto, Y., Yuki, N., Van Kaer, L., Furukawa, K., Hirata, K. and Sugita, M. (2008) Guillain-Barré syndrome-associated IgG responses to gangliosides are generated independently of CD1 function in mice. J. Immunol. 180, 39-43.
180. Yuki, N. (2001) Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect. Dis. 1, 29-37.
181. Willison, H.J. and Yuki, N. (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125, 2591-2625.
182. Susuki, K., Koga, M., Hirata, K., Isogai, E. and Yuki, N. (2009) A Guillain-Barré syndrome variant with prominent facial diplegia. J. Neurol. 256, 1899-1905.
183. Yuki, N. (2007) Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35, 691-711.
184. Yuki, N. (2010) Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies. Methods Mol. Biol. 600, 51-65.
185. Yuki, N., Ichikawa, H. and Doi, A. (1995) Fisher syndrome after Campylobacter jejuni enteritis: Human leukocyte antigen and the bacterial serotype. J. Pediatr. 126, 55-57.
186. Yuki, N. and Hartung, H.P. (2012) Guillain-Barré syndrome. N. Engl. J. Med. 366, 2294-2304.